SHANGHAI, Aug. 28, 2026 /PRNewswire/ -- Asieris Pharmaceuticals today released its 2026 Semi-Annual Report, showing comprehensive progress across all business segments. With the gradual realization of commercial launch and international expansion for its core products, the company is accelerating its transition from Biotech to Biopharma: CEVIRA®, the world's first...
SHANGHAI, Feb. 13, 2025 /PRNewswire/ -- OneConnect Financial Technology Co., Ltd ("OneConnect" or the "Company", NYSE: OCFT, HKSE: 6638), a business technology service provider...
SHANGHAI, Feb. 13, 2025 /PRNewswire/ -- Jinxin Technology Holding Company (the "Company") (Nasdaq: NAMI), an innovative provider of digital-content products and services in China,...
The Only Forbes-Starred Hotel in Xiamen XIAMEN, China, Feb. 13, 2025 /PRNewswire/ -- Conrad Xiamen proudly announces its Four-Star recognition in the 2025 Forbes...
NEW YORK, Feb. 13, 2025 /PRNewswire/ -- Accropeutics Inc. (Accropeutics), a clinical-stage biotechnology company pioneering the development of novel therapeutics that target molecular mechanisms...